Nagasato-Ichikawa A, Murakami K, Aoki K, Okada M, et al. The receptor tyrosine kinase ErbB2/HER2 governs CDK4 inhibitor sensitivity, timing, and irreversibility of the G1/S transition. J Biol Chem 2025;301:110865.
PMID: 41161384